Global Placental Stem Cell Therapy for Neurological Disorders Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 02 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Placental Stem Cell Therapy for Neurological Disorders market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Placental stem cell therapy for neurological disorders involves the use of stem cells derived from the placenta to treat conditions affecting the nervous system. These cells have the potential to differentiate into various specialized cell types, promoting neural regeneration and repair. This therapeutic approach aims to address conditions like Parkinson's disease, Alzheimer's, and spinal cord injuries, offering a promising avenue for regenerative medicine in neurology by harnessing the regenerative capabilities of placental-derived stem cells.

The industry trend for placental stem cell therapy in neurological disorders is marked by ongoing research and clinical trials to explore its efficacy and safety. As advancements in stem cell technology and understanding of neurobiology progress, there's a growing interest in developing targeted and personalized therapies. Regulatory frameworks are evolving to accommodate these innovative treatments. The trend also involves collaborations between academia, biotech companies, and healthcare institutions to accelerate the translation of research findings into practical and accessible therapeutic solutions, reflecting a positive outlook for the integration of placental stem cell therapy into neurological care.

The Global Info Research report includes an overview of the development of the Placental Stem Cell Therapy for Neurological Disorders industry chain, the market status of Hospitals and Specialist Clinics (Allogeneic Placental Stem Cell Therapy, Autologous Placental Stem Cell Therapy), Clinical Research Institute (Allogeneic Placental Stem Cell Therapy, Autologous Placental Stem Cell Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Placental Stem Cell Therapy for Neurological Disorders.

Regionally, the report analyzes the Placental Stem Cell Therapy for Neurological Disorders markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Placental Stem Cell Therapy for Neurological Disorders market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Placental Stem Cell Therapy for Neurological Disorders market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Placental Stem Cell Therapy for Neurological Disorders industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Allogeneic Placental Stem Cell Therapy, Autologous Placental Stem Cell Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Placental Stem Cell Therapy for Neurological Disorders market.

Regional Analysis: The report involves examining the Placental Stem Cell Therapy for Neurological Disorders market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Placental Stem Cell Therapy for Neurological Disorders market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Placental Stem Cell Therapy for Neurological Disorders:
Company Analysis: Report covers individual Placental Stem Cell Therapy for Neurological Disorders players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Placental Stem Cell Therapy for Neurological Disorders This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Specialist Clinics, Clinical Research Institute).

Technology Analysis: Report covers specific technologies relevant to Placental Stem Cell Therapy for Neurological Disorders. It assesses the current state, advancements, and potential future developments in Placental Stem Cell Therapy for Neurological Disorders areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Placental Stem Cell Therapy for Neurological Disorders market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Placental Stem Cell Therapy for Neurological Disorders market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Allogeneic Placental Stem Cell Therapy
    Autologous Placental Stem Cell Therapy

Market segment by Application
    Hospitals and Specialist Clinics
    Clinical Research Institute

Market segment by players, this report covers
    Mesoblast
    Pleurite Therapeutic
    Athersys
    Cordlife India
    Life Cell
    Cryo-Cell
    CBR Systems
    ReNeuron Group
    Cynata
    Celularity
    Americord Registry
    ReeLabs
    Mesoblast

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Placental Stem Cell Therapy for Neurological Disorders product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Placental Stem Cell Therapy for Neurological Disorders, with revenue, gross margin and global market share of Placental Stem Cell Therapy for Neurological Disorders from 2018 to 2023.
Chapter 3, the Placental Stem Cell Therapy for Neurological Disorders competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Placental Stem Cell Therapy for Neurological Disorders market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Placental Stem Cell Therapy for Neurological Disorders.
Chapter 13, to describe Placental Stem Cell Therapy for Neurological Disorders research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Placental Stem Cell Therapy for Neurological Disorders
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Placental Stem Cell Therapy for Neurological Disorders by Type
        1.3.1 Overview: Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Type in 2022
        1.3.3 Allogeneic Placental Stem Cell Therapy
        1.3.4 Autologous Placental Stem Cell Therapy
    1.4 Global Placental Stem Cell Therapy for Neurological Disorders Market by Application
        1.4.1 Overview: Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals and Specialist Clinics
        1.4.3 Clinical Research Institute
    1.5 Global Placental Stem Cell Therapy for Neurological Disorders Market Size & Forecast
    1.6 Global Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast by Region
        1.6.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region, (2018-2029)
        1.6.3 North America Placental Stem Cell Therapy for Neurological Disorders Market Size and Prospect (2018-2029)
        1.6.4 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size and Prospect (2018-2029)
        1.6.6 South America Placental Stem Cell Therapy for Neurological Disorders Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Placental Stem Cell Therapy for Neurological Disorders Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Mesoblast
        2.1.1 Mesoblast Details
        2.1.2 Mesoblast Major Business
        2.1.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.1.4 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Mesoblast Recent Developments and Future Plans
    2.2 Pleurite Therapeutic
        2.2.1 Pleurite Therapeutic Details
        2.2.2 Pleurite Therapeutic Major Business
        2.2.3 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.2.4 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Pleurite Therapeutic Recent Developments and Future Plans
    2.3 Athersys
        2.3.1 Athersys Details
        2.3.2 Athersys Major Business
        2.3.3 Athersys Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.3.4 Athersys Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Athersys Recent Developments and Future Plans
    2.4 Cordlife India
        2.4.1 Cordlife India Details
        2.4.2 Cordlife India Major Business
        2.4.3 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.4.4 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Cordlife India Recent Developments and Future Plans
    2.5 Life Cell
        2.5.1 Life Cell Details
        2.5.2 Life Cell Major Business
        2.5.3 Life Cell Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.5.4 Life Cell Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Life Cell Recent Developments and Future Plans
    2.6 Cryo-Cell
        2.6.1 Cryo-Cell Details
        2.6.2 Cryo-Cell Major Business
        2.6.3 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.6.4 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Cryo-Cell Recent Developments and Future Plans
    2.7 CBR Systems
        2.7.1 CBR Systems Details
        2.7.2 CBR Systems Major Business
        2.7.3 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.7.4 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 CBR Systems Recent Developments and Future Plans
    2.8 ReNeuron Group
        2.8.1 ReNeuron Group Details
        2.8.2 ReNeuron Group Major Business
        2.8.3 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.8.4 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 ReNeuron Group Recent Developments and Future Plans
    2.9 Cynata
        2.9.1 Cynata Details
        2.9.2 Cynata Major Business
        2.9.3 Cynata Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.9.4 Cynata Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Cynata Recent Developments and Future Plans
    2.10 Celularity
        2.10.1 Celularity Details
        2.10.2 Celularity Major Business
        2.10.3 Celularity Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.10.4 Celularity Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Celularity Recent Developments and Future Plans
    2.11 Americord Registry
        2.11.1 Americord Registry Details
        2.11.2 Americord Registry Major Business
        2.11.3 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.11.4 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Americord Registry Recent Developments and Future Plans
    2.12 ReeLabs
        2.12.1 ReeLabs Details
        2.12.2 ReeLabs Major Business
        2.12.3 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.12.4 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 ReeLabs Recent Developments and Future Plans
    2.13 Mesoblast
        2.13.1 Mesoblast Details
        2.13.2 Mesoblast Major Business
        2.13.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
        2.13.4 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Mesoblast Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Placental Stem Cell Therapy for Neurological Disorders Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Placental Stem Cell Therapy for Neurological Disorders by Company Revenue
        3.2.2 Top 3 Placental Stem Cell Therapy for Neurological Disorders Players Market Share in 2022
        3.2.3 Top 6 Placental Stem Cell Therapy for Neurological Disorders Players Market Share in 2022
    3.3 Placental Stem Cell Therapy for Neurological Disorders Market: Overall Company Footprint Analysis
        3.3.1 Placental Stem Cell Therapy for Neurological Disorders Market: Region Footprint
        3.3.2 Placental Stem Cell Therapy for Neurological Disorders Market: Company Product Type Footprint
        3.3.3 Placental Stem Cell Therapy for Neurological Disorders Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Application (2018-2023)
    5.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2018-2029)
    6.2 North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2018-2029)
    6.3 North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country
        6.3.1 North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Country (2018-2029)
        6.3.2 United States Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        6.3.3 Canada Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        6.3.4 Mexico Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2018-2029)
    7.2 Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2018-2029)
    7.3 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country
        7.3.1 Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Country (2018-2029)
        7.3.2 Germany Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        7.3.3 France Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        7.3.5 Russia Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        7.3.6 Italy Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region
        8.3.1 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Region (2018-2029)
        8.3.2 China Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        8.3.3 Japan Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        8.3.4 South Korea Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        8.3.5 India Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        8.3.7 Australia Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2018-2029)
    9.2 South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2018-2029)
    9.3 South America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country
        9.3.1 South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Country (2018-2029)
        9.3.2 Brazil Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        9.3.3 Argentina Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country
        10.3.1 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Country (2018-2029)
        10.3.2 Turkey Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)
        10.3.4 UAE Placental Stem Cell Therapy for Neurological Disorders Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Placental Stem Cell Therapy for Neurological Disorders Market Drivers
    11.2 Placental Stem Cell Therapy for Neurological Disorders Market Restraints
    11.3 Placental Stem Cell Therapy for Neurological Disorders Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Placental Stem Cell Therapy for Neurological Disorders Industry Chain
    12.2 Placental Stem Cell Therapy for Neurological Disorders Upstream Analysis
    12.3 Placental Stem Cell Therapy for Neurological Disorders Midstream Analysis
    12.4 Placental Stem Cell Therapy for Neurological Disorders Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Mesoblast Company Information, Head Office, and Major Competitors
    Table 6. Mesoblast Major Business
    Table 7. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 8. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Mesoblast Recent Developments and Future Plans
    Table 10. Pleurite Therapeutic Company Information, Head Office, and Major Competitors
    Table 11. Pleurite Therapeutic Major Business
    Table 12. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 13. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Pleurite Therapeutic Recent Developments and Future Plans
    Table 15. Athersys Company Information, Head Office, and Major Competitors
    Table 16. Athersys Major Business
    Table 17. Athersys Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 18. Athersys Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Athersys Recent Developments and Future Plans
    Table 20. Cordlife India Company Information, Head Office, and Major Competitors
    Table 21. Cordlife India Major Business
    Table 22. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 23. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Cordlife India Recent Developments and Future Plans
    Table 25. Life Cell Company Information, Head Office, and Major Competitors
    Table 26. Life Cell Major Business
    Table 27. Life Cell Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 28. Life Cell Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Life Cell Recent Developments and Future Plans
    Table 30. Cryo-Cell Company Information, Head Office, and Major Competitors
    Table 31. Cryo-Cell Major Business
    Table 32. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 33. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Cryo-Cell Recent Developments and Future Plans
    Table 35. CBR Systems Company Information, Head Office, and Major Competitors
    Table 36. CBR Systems Major Business
    Table 37. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 38. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. CBR Systems Recent Developments and Future Plans
    Table 40. ReNeuron Group Company Information, Head Office, and Major Competitors
    Table 41. ReNeuron Group Major Business
    Table 42. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 43. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. ReNeuron Group Recent Developments and Future Plans
    Table 45. Cynata Company Information, Head Office, and Major Competitors
    Table 46. Cynata Major Business
    Table 47. Cynata Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 48. Cynata Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Cynata Recent Developments and Future Plans
    Table 50. Celularity Company Information, Head Office, and Major Competitors
    Table 51. Celularity Major Business
    Table 52. Celularity Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 53. Celularity Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Celularity Recent Developments and Future Plans
    Table 55. Americord Registry Company Information, Head Office, and Major Competitors
    Table 56. Americord Registry Major Business
    Table 57. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 58. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. Americord Registry Recent Developments and Future Plans
    Table 60. ReeLabs Company Information, Head Office, and Major Competitors
    Table 61. ReeLabs Major Business
    Table 62. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 63. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. ReeLabs Recent Developments and Future Plans
    Table 65. Mesoblast Company Information, Head Office, and Major Competitors
    Table 66. Mesoblast Major Business
    Table 67. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product and Solutions
    Table 68. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. Mesoblast Recent Developments and Future Plans
    Table 70. Global Placental Stem Cell Therapy for Neurological Disorders Revenue (USD Million) by Players (2018-2023)
    Table 71. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Share by Players (2018-2023)
    Table 72. Breakdown of Placental Stem Cell Therapy for Neurological Disorders by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 73. Market Position of Players in Placental Stem Cell Therapy for Neurological Disorders, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 74. Head Office of Key Placental Stem Cell Therapy for Neurological Disorders Players
    Table 75. Placental Stem Cell Therapy for Neurological Disorders Market: Company Product Type Footprint
    Table 76. Placental Stem Cell Therapy for Neurological Disorders Market: Company Product Application Footprint
    Table 77. Placental Stem Cell Therapy for Neurological Disorders New Market Entrants and Barriers to Market Entry
    Table 78. Placental Stem Cell Therapy for Neurological Disorders Mergers, Acquisition, Agreements, and Collaborations
    Table 79. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value (USD Million) by Type (2018-2023)
    Table 80. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value Share by Type (2018-2023)
    Table 81. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value Forecast by Type (2024-2029)
    Table 82. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2018-2023)
    Table 83. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value Forecast by Application (2024-2029)
    Table 84. North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2018-2023) & (USD Million)
    Table 85. North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2024-2029) & (USD Million)
    Table 86. North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2018-2023) & (USD Million)
    Table 87. North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2024-2029) & (USD Million)
    Table 88. North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Country (2018-2023) & (USD Million)
    Table 89. North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Country (2024-2029) & (USD Million)
    Table 90. Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2018-2023) & (USD Million)
    Table 91. Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2024-2029) & (USD Million)
    Table 92. Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2018-2023) & (USD Million)
    Table 93. Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2024-2029) & (USD Million)
    Table 94. Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Country (2018-2023) & (USD Million)
    Table 95. Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Country (2024-2029) & (USD Million)
    Table 96. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2018-2023) & (USD Million)
    Table 97. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2024-2029) & (USD Million)
    Table 98. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2018-2023) & (USD Million)
    Table 99. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2024-2029) & (USD Million)
    Table 100. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Region (2018-2023) & (USD Million)
    Table 101. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Region (2024-2029) & (USD Million)
    Table 102. South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2018-2023) & (USD Million)
    Table 103. South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2024-2029) & (USD Million)
    Table 104. South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2018-2023) & (USD Million)
    Table 105. South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2024-2029) & (USD Million)
    Table 106. South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Country (2018-2023) & (USD Million)
    Table 107. South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Country (2024-2029) & (USD Million)
    Table 108. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2018-2023) & (USD Million)
    Table 109. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type (2024-2029) & (USD Million)
    Table 110. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2018-2023) & (USD Million)
    Table 111. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Application (2024-2029) & (USD Million)
    Table 112. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Country (2018-2023) & (USD Million)
    Table 113. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Country (2024-2029) & (USD Million)
    Table 114. Placental Stem Cell Therapy for Neurological Disorders Raw Material
    Table 115. Key Suppliers of Placental Stem Cell Therapy for Neurological Disorders Raw Materials
List of Figures
    Figure 1. Placental Stem Cell Therapy for Neurological Disorders Picture
    Figure 2. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Type in 2022
    Figure 4. Allogeneic Placental Stem Cell Therapy
    Figure 5. Autologous Placental Stem Cell Therapy
    Figure 6. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Application in 2022
    Figure 8. Hospitals and Specialist Clinics Picture
    Figure 9. Clinical Research Institute Picture
    Figure 10. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Market Placental Stem Cell Therapy for Neurological Disorders Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 13. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Region (2018-2029)
    Figure 14. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Region in 2022
    Figure 15. North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 16. Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 17. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 18. South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 19. Middle East and Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 20. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Share by Players in 2022
    Figure 21. Placental Stem Cell Therapy for Neurological Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 22. Global Top 3 Players Placental Stem Cell Therapy for Neurological Disorders Market Share in 2022
    Figure 23. Global Top 6 Players Placental Stem Cell Therapy for Neurological Disorders Market Share in 2022
    Figure 24. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value Share by Type (2018-2023)
    Figure 25. Global Placental Stem Cell Therapy for Neurological Disorders Market Share Forecast by Type (2024-2029)
    Figure 26. Global Placental Stem Cell Therapy for Neurological Disorders Consumption Value Share by Application (2018-2023)
    Figure 27. Global Placental Stem Cell Therapy for Neurological Disorders Market Share Forecast by Application (2024-2029)
    Figure 28. North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Type (2018-2029)
    Figure 29. North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Application (2018-2029)
    Figure 30. North America Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Country (2018-2029)
    Figure 31. United States Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 32. Canada Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 33. Mexico Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 34. Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Type (2018-2029)
    Figure 35. Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Application (2018-2029)
    Figure 36. Europe Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Country (2018-2029)
    Figure 37. Germany Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 38. France Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 39. United Kingdom Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 40. Russia Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 41. Italy Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 42. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Type (2018-2029)
    Figure 43. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Application (2018-2029)
    Figure 44. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Region (2018-2029)
    Figure 45. China Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 46. Japan Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 47. South Korea Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 48. India Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 49. Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 50. Australia Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 51. South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Type (2018-2029)
    Figure 52. South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Application (2018-2029)
    Figure 53. South America Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Country (2018-2029)
    Figure 54. Brazil Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 55. Argentina Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 56. Middle East and Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Type (2018-2029)
    Figure 57. Middle East and Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Application (2018-2029)
    Figure 58. Middle East and Africa Placental Stem Cell Therapy for Neurological Disorders Consumption Value Market Share by Country (2018-2029)
    Figure 59. Turkey Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 60. Saudi Arabia Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 61. UAE Placental Stem Cell Therapy for Neurological Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 62. Placental Stem Cell Therapy for Neurological Disorders Market Drivers
    Figure 63. Placental Stem Cell Therapy for Neurological Disorders Market Restraints
    Figure 64. Placental Stem Cell Therapy for Neurological Disorders Market Trends
    Figure 65. Porters Five Forces Analysis
    Figure 66. Manufacturing Cost Structure Analysis of Placental Stem Cell Therapy for Neurological Disorders in 2022
    Figure 67. Manufacturing Process Analysis of Placental Stem Cell Therapy for Neurological Disorders
    Figure 68. Placental Stem Cell Therapy for Neurological Disorders Industrial Chain
    Figure 69. Methodology
    Figure 70. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Mesoblast
Pleurite Therapeutic
Athersys
Cordlife India
Life Cell
Cryo-Cell
CBR Systems
ReNeuron Group
Cynata
Celularity
Americord Registry
ReeLabs
Mesoblast

Related Reports

Global Placental Stem Cell Therapy for Neurological Disorders Supply, Demand and Key Producers, 2023-2029

Global Placental Stem Cell Therapy for Neurological Disorders Supply, Demand and Key Producers, 2023-2029

date 02 Jan 2024

date Medical Care

The global Placental Stem Cell Therapy for Neurological Disorders market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Placental Stem Cell Therapy for Neurological Disorders Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Placental Stem Cell Therapy for Neurological Disorders Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 20 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Placental Stem Cell Therapy for Neurological Disorders market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Placental Stem Cell Therapy for Neurological Disorders

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>